Metabolon Plans to Double Staff as it Launches Diagnostics Unit

Life sciences technology company Metabolon has more than doubled its workforce in the past 24 months and expects to double it again during the next two years as it diversifies its business. John Ryals, CEO of the privately held Durham company, sees its coming diagnostics business as having even greater potential than its existing analytics services business. Metabolon's analytics work for drug and consumer product companies and universities generated $14 million in revenue last year, double the 2009 total.